BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10229815)

  • 1. CTLA-4-Mediated inhibition of early events of T cell proliferation.
    Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
    J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging impairs induction of cyclin-dependent kinases and down-regulation of p27 in mouse CD4(+) cells.
    Tamir A; Miller RA
    Cell Immunol; 1999 Nov; 198(1):11-20. PubMed ID: 10612647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
    Kubsch S; Graulich E; Knop J; Steinbrink K
    Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
    Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
    Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.
    Hamel ME; Leupers TJ; Kruisbeek AM
    Thymus; 1997; 24(4):259-77. PubMed ID: 9493288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T cell proliferation by cholera toxin involves the modulation of costimulatory molecules CTLA-4 and CD28.
    Vendetti S; Riccomi A; Sacchi A; Sciaraffia E; Gatta L; Pioli C; De Magistris MT
    Immunol Lett; 2008 Jan; 115(1):59-69. PubMed ID: 18031829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of CD28-CD80 interactions impairs CD28-mediated costimulation of human CD4 T cells.
    Fine JS; Macosko HD; Justice L; Chou CC; Jenh CH; Narula SK; Zavodny PJ
    Cell Immunol; 1999 Jan; 191(1):49-59. PubMed ID: 9918686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
    Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
    Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
    J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
    Nourse J; Firpo E; Flanagan WM; Coats S; Polyak K; Lee MH; Massague J; Crabtree GR; Roberts JM
    Nature; 1994 Dec; 372(6506):570-3. PubMed ID: 7990932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
    Shapiro VS; Mollenauer MN; Weiss A
    J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.